Request Advisory Consultation

FertilityCareHub Country Intelligence

Global Fertility Jurisdiction Dossiers

Explore structured country intelligence covering fertility regulation, eligibility, donor pathways, clinical infrastructure, clinic and laboratory governance, logistics, documentation, costs, and execution risk.

These dossiers are designed as strategic planning resources rather than public clinic rankings, promotional destination lists, or substitutes for individualized medical and legal advice.

Before choosing a destination

Compare countries before comparing clinics

Use the strategic comparison framework to identify which jurisdictions fit your legal, medical, donor, financial, documentation, timeline, and logistical requirements before evaluating individual providers.

A strong clinic cannot solve a jurisdiction mismatch. Country fit should therefore be established before marketing claims, headline success rates, package prices, or travel convenience influence the decision.

Read the jurisdiction comparison guide →

Browse the knowledge library

Build decision quality with structured guides

Explore planning guides covering clinic selection, success-rate interpretation, hidden costs, travel preparation, donor pathways, documentation, and cross-border decision risk.

Use the Guides Library alongside each country dossier to test assumptions, identify missing information, and prepare stronger questions for clinics and licensed professionals.

Browse all fertility guides →

Independent methodology

FCH Global Fertility Intelligence Framework

Country dossiers are developed using the FCH Global Fertility Intelligence Framework. Jurisdictions are considered across regulatory alignment, access, donor policy, clinical infrastructure, clinic and laboratory governance, coordination burden, documentation, cost exposure, and execution complexity.

The objective is not to identify a universally best destination. It is to determine which jurisdiction is most aligned with a specific treatment pathway, personal profile, timeline, budget, legal position, and tolerance for operational risk.

01

Regulation and eligibility

Confirm what treatment is legally permitted, who is eligible, and which approvals, relationships, or documents are required.

02

Clinic and laboratory governance

Assess licensing, medical leadership, embryology quality systems, inspection history, reporting, and continuity of responsibility.

03

Donor and family-building pathways

Compare donor access, identity rules, consent, parenthood, surrogacy, storage, and pathway-specific restrictions.

04

Costs and financial exposure

Separate treatment, medication, testing, laboratory services, storage, travel, legal work, and contingency costs.

05

Timeline and execution

Evaluate waiting times, monitoring, medication, travel windows, communication, documentation, and follow-up.

06

Personal pathway fit

Choose the jurisdiction aligned with your medical needs, legal status, donor requirements, timeline, budget, and tolerance for complexity.

Eleven published dossiers

Explore Fertility Treatment Countries

Begin with the countries most relevant to your pathway, then compare a focused shortlist rather than treating every destination as equally suitable.

Each dossier explains strategic fit, regulatory structure, eligibility, donor pathways, clinic assessment, cost planning, documentation, travel, and the circumstances in which another jurisdiction may be more appropriate.

Spain

Europe

Published

Strategic advisory dossier

A mature European destination with established international-patient pathways and significant donor-treatment experience.

Assessment focus

Donor access, clinic governance, eligibility, success-rate interpretation, costs, and travel execution.

View dossier →

Greece

Europe

Published

Strategic advisory dossier

A prominent European treatment destination where regulation, donor access, clinic quality, costs, and travel planning require careful comparison.

Assessment focus

Eligibility, donor pathways, clinic selection, pricing transparency, timelines, and international coordination.

View dossier →

Portugal

Europe

Published

Strategic advisory dossier

A regulated European option with growing international visibility, strong private care, and pathway-specific access considerations.

Assessment focus

Regulatory fit, clinic capability, donor rules, documentation, cost exposure, and treatment logistics.

View dossier →

Czech Republic

Europe

Published

Strategic advisory dossier

A well-established Central European destination where donor access, eligibility, clinic quality, costs, and logistics should be assessed together.

Assessment focus

Eligibility, donor-treatment structure, laboratory governance, pricing, travel planning, and continuity of care.

View dossier →

United Kingdom

Europe

Published

Strategic advisory dossier

A highly regulated system shaped by HFEA oversight, NHS and private access, donor rules, waiting times, and transparent clinic reporting.

Assessment focus

HFEA licensing, NHS eligibility, private treatment, donor pathways, waiting times, and total cost.

View dossier →

Canada

North America

Published

Strategic advisory dossier

A regulated, ethics-forward system where provincial access, clinic capacity, funding, and continuity of care shape the pathway.

Assessment focus

Provincial funding, clinic access, donor restrictions, wait times, costs, and domestic continuity of care.

View dossier →

United States

North America

Published

Strategic advisory dossier

A large and highly varied fertility market with broad specialist depth, higher costs, and important state-level considerations.

Assessment focus

State-level law, specialist capability, donor and surrogacy pathways, clinic quality, insurance, and cost exposure.

View dossier →

India

Asia

Published

Strategic advisory dossier

A large and diverse treatment market where regulation, clinic governance, costs, documentation, and execution discipline are decisive.

Assessment focus

Eligibility, treatment restrictions, clinic vetting, laboratory standards, documentation, pricing, and travel execution.

View dossier →

Turkey

Europe and Asia

Published

Strategic advisory dossier

A major private medical market where eligibility, clinic quality, treatment restrictions, costs, and travel execution must be confirmed carefully.

Assessment focus

Legal treatment scope, patient eligibility, clinic governance, pricing, medications, travel, and follow-up.

View dossier →

Mexico

North America

Published

Strategic advisory dossier

A geographically accessible treatment market where state-level variation, clinic governance, pricing, and continuity of care require close review.

Assessment focus

State-level legal context, clinic standards, communication, costs, travel convenience, and post-treatment coordination.

View dossier →

China

Asia

Published

Strategic advisory dossier

A tightly controlled fertility system where lawful treatment scope, patient eligibility, institutional access, documentation, and coordination come first.

Assessment focus

Eligibility, institutional access, documentation, lawful treatment scope, governance, communication, and continuity.

View dossier →

Shortlist discipline

Questions every country comparison should answer

Destination decisions become more reliable when each country is tested against the same legal, medical, financial, and operational questions.

  1. 1

    Is the required treatment lawful and accessible for your personal circumstances?

  2. 2

    Does the country offer the donor, parenthood, or family-building pathway you need?

  3. 3

    Can the clinic demonstrate appropriate licensing, governance, laboratory capability, and transparent reporting?

  4. 4

    Are the quoted costs complete enough to estimate the full pathway rather than only the base cycle?

  5. 5

    Can monitoring, medication, travel, accommodation, procedures, recovery, and follow-up be coordinated safely?

  6. 6

    What happens if treatment is delayed, cancelled, unsuccessful, or requires another cycle?

Compare jurisdictions

Review country-to-country differences directly

Review available country comparisons and evaluate regulatory, donor, clinical, financial, timeline, documentation, and logistical differences across shortlisted jurisdictions.

Comparison briefs help reveal trade-offs that are difficult to see when destinations are researched separately.

View jurisdiction comparisons →

Private advisory

Need help identifying the right jurisdiction path?

FertilityCareHub can structure the jurisdiction decision around your treatment profile, priorities, legal position, donor needs, timeline, budget, travel capacity, documentation, and tolerance for complexity.

Advisory is selective and decision-focused. It is not a public clinic directory, paid ranking system, or substitute for licensed professional advice.

Important planning note

Country rules and clinic practices can change

Laws, eligibility criteria, donor availability, NHS or public funding, clinic policies, waiting times, documentation requirements, treatment prices, and clinical practices may change. Information should always be verified directly with appropriately licensed clinics, medical professionals, lawyers, and relevant regulatory bodies before treatment or travel is arranged.

FertilityCareHub provides general educational and strategic planning information. It does not provide medical, legal, financial, immigration, or regulatory advice. No country, clinic, treatment, donor pathway, or outcome is guaranteed. All material decisions should be independently confirmed with appropriately licensed professionals.